Dennis Kordie

NPI: 1447640362
Total Payments
$1,512
2024 Payments
$701.60
Companies
11
Transactions
43
Medicare Patients
709
Medicare Billing
$115,495

Payment Breakdown by Category

Food & Beverage$1,512 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,512 43 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $552.37 10 $0 (2024)
Janssen Pharmaceuticals, Inc $240.79 14 $0 (2024)
Abbott Laboratories $141.97 1 $0 (2024)
Vanda Pharmaceuticals Inc. $125.00 1 $0 (2024)
Alkermes, Inc. $110.45 1 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $97.17 1 $0 (2024)
Merck Sharp & Dohme LLC $78.55 4 $0 (2023)
E.R. Squibb & Sons, L.L.C. $72.18 5 $0 (2023)
PFIZER INC. $65.33 4 $0 (2024)
Janssen Biotech, Inc. $14.88 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $701.60 11 ABBVIE INC. ($142.93)
2023 $593.72 19 ABBVIE INC. ($344.31)
2022 $70.82 5 E.R. Squibb & Sons, L.L.C. ($55.74)
2021 $145.88 8 Janssen Pharmaceuticals, Inc ($67.50)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/04/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $16.33 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/23/2024 Abbott Laboratories AMPLATZER AMULET (Device) Food and Beverage In-kind items and services $141.97 General
Category: Structural Heart
08/13/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.75 General
Category: Cardiovascular & Metabolism
07/31/2024 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $17.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/10/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: SCHIZOPHRENIA
05/08/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT, ZAVZPRET Food and Beverage In-kind items and services $17.00 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
03/07/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $97.17 General
02/28/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Cardiovascular & Metabolism
02/21/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $110.45 General
Category: CNS
01/25/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $125.00 General
Category: NEUROSCIENCE
01/17/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $17.93 General
Category: ANTI-INFECTIVE
12/07/2023 ABBVIE INC. Food and Beverage In-kind items and services $100.00 General
12/06/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.00 General
Category: Cardiovascular & Metabolism
09/28/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.00 General
Category: Cardiovascular & Metabolism
09/14/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $103.83 General
Category: NEUROSCIENCE
07/06/2023 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $17.93 General
Category: INFECTIOUS DISEASE
06/29/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.45 General
Category: Cardiovascular & Metabolism
06/28/2023 Janssen Biotech, Inc. Food and Beverage In-kind items and services $14.88 General
06/20/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.75 General
Category: NEUROSCIENCE
06/15/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $16.44 General
Category: Cardiovascular
05/31/2023 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $18.31 General
Category: INFECTIOUS DISEASE
05/15/2023 Merck Sharp & Dohme LLC DIFICID (Drug), RECARBRIO, ZERBAXA Food and Beverage In-kind items and services $21.12 General
Category: INFECTIOUS DISEASE
05/09/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $124.73 General
Category: NEUROSCIENCE
05/03/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.89 General
Category: Cardiovascular & Metabolism
04/17/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.63 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 187 405 $176,799 $32,321
2022 3 158 408 $134,005 $25,449
2021 3 164 474 $165,131 $33,087
2020 6 200 338 $183,942 $24,637
Total Patients
709
Total Services
1,625
Medicare Billing
$115,495
Procedure Codes
15

All Medicare Procedures & Services

15 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 76 234 $115,758 $20,702 17.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 56 113 $32,455 $6,648 20.5%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 55 58 $28,586 $4,971 17.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 68 193 $72,447 $13,599 18.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 59 180 $47,803 $9,197 19.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 31 35 $13,755 $2,654 19.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 84 309 $117,703 $23,612 20.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 52 137 $36,431 $7,223 19.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 28 28 $10,997 $2,253 20.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 42 114 $37,152 $9,035 24.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 61 120 $27,664 $6,557 23.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 34 37 $65,009 $4,404 6.8%
99284 Emergency department visit, problem of high severity Facility 2020 27 30 $35,820 $2,502 7.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 19 19 $6,957 $1,554 22.3%
99283 Emergency department visit, moderately severe problem Facility 2020 17 18 $11,340 $584.65 5.2%

About Dennis Kordie

Dennis Kordie is a Family healthcare provider based in East Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1447640362.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dennis Kordie has received a total of $1,512 in payments from pharmaceutical and medical device companies, with $701.60 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,512).

As a Medicare-enrolled provider, Kordie has provided services to 709 Medicare beneficiaries, totaling 1,625 services with total Medicare billing of $115,495. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location East Orange, NJ
  • Active Since 01/30/2015
  • Last Updated 01/07/2025
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1447640362

Products in Payments

  • VRAYLAR (Drug) $369.31
  • XARELTO (Drug) $240.79
  • AMPLATZER AMULET (Device) $141.97
  • FANAPT (Drug) $125.00
  • VIVITROL (Drug) $110.45
  • TEFLARO (Drug) $83.06
  • ELIQUIS (Drug) $79.00
  • DIFICID (Drug) $78.55
  • CAMZYOS (Drug) $58.51
  • LOKELMA (Drug) $13.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in East Orange